Fresh analysis indicates that individuals who come off blockbuster weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who end traditional diet and exercise programs.
Published data in a leading health publication shows that while obese individuals often shed substantial amounts of their body weight while using the jabs, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.
"People buying such medications need to be cognizant of the danger of fast rebound weight gain when the medication ends," stated expert Dr. Susan Jebb.
Such speed of recovery suggests a reversion to original mass in about one and a half years.
Comparing Treatments
The research, which reviewed 37 of studies involving thousands of patients, contrasted the effects of these new drugs with older methods.
Scientists emphasize that individuals who lose weight through diet and exercise typically have a slower weight regain—perhaps 0.1 kg a month—once they finish.
Understanding the Quick Regain
Nutrition scientists suggest the mode of action of the injections accounts for the amplified rebound.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations far above than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication leads to appetite is no longer kept in check, making binge eating far more likely."
An Ongoing Condition?
The NHS suggest the injections for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Many experts argue that, given the high risk of relapse, the therapy might need to be ongoing.
This perspective is supported by pharmaceutical companies, who say that the findings "emphasize the chronic nature of excess weight," comparing it to managing diseases like diabetes.
Patient Testimonies
Users who have discontinued the jabs report a sudden resurgence of appetite.
"It felt as if something activating and you're instantly extremely hungry," said a patient.
This challenge is exacerbated if individuals have not developed permanent lifestyle or habit modifications during therapy.
Widespread Use
Survey data show that millions of people in the UK have tried these injections in the past year, with desire remaining high.
- Use is greater among women compared to men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while these medications are effective tools for shedding pounds, they are not a standalone cure and maintained weight loss likely depends on integrated lifestyle support.
